1.北京中医医院顺义医院心血管内科,北京 101300
2.首都医科大学附属北京中医医院心血管内科, 北京 100010
吴颖,女,41,硕士,副主任医师。研究方向:心血管疾病的中医诊治。
周琦,E-mail:37549558@163.com
纸质出版日期:2024-04-25,
收稿日期:2022-10-24,
扫 描 看 全 文
吴颖,王巍,陈琳,等.泻肺利水合剂治疗慢性心力衰竭患者的临床疗效评价[J].北京中医药,2024,43(4):362-365.
WU Ying,WANG Wei,CHEN Lin,et al.Clinical effect evaluation on the treatment of chronic heart failure using Xiefei Lishui Mixture[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):362-365.
吴颖,王巍,陈琳,等.泻肺利水合剂治疗慢性心力衰竭患者的临床疗效评价[J].北京中医药,2024,43(4):362-365. DOI: 10.16025/j.1674-1307.2024.04.005.
WU Ying,WANG Wei,CHEN Lin,et al.Clinical effect evaluation on the treatment of chronic heart failure using Xiefei Lishui Mixture[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):362-365. DOI: 10.16025/j.1674-1307.2024.04.005.
目的
2
观察泻肺利水合剂治疗气虚血瘀兼阳虚水泛型慢性心力衰竭(CHF)的临床疗效。
方法
2
选择2020年1月—2022年6月在首都医科大学附属北京中医医院和北京中医医院顺义医院心内科病房收治的CHF患者99例,按随机数字表法分成观察组49例与对照组50例。对照组给予西医常规治疗,加口服中药安慰剂治疗,每次100 mL,2次/d,早晚餐后服用;观察组给予西医常规治疗,加首都医科大学附属北京中医医院的院内制剂泻肺利水合剂口服治疗,每次100 mL,2次/d,温服。2组疗程均为6周。对比2组治疗前后血清N端脑钠肽前体(NT-proBNP)水平、心脏输出量(CO)、左室射血分数(LVEF)、每搏输出量(SV)、左室舒张末期容积(LVEDV),左心室收缩末期容积(LVESV),二尖瓣口舒张早期流速峰值与舒张晚期流速峰值比值(E/A),再次住院频次及不良事件、疗效。
结果
2
治疗2、6周,2组血清NT-proBNP水平均较治疗前降低(
P
<
0.05),且观察组低于对照组(
P
<
0.05)。治疗2、6周,观察组LVEDV、LVESV、LVEF、E/A、SV与对照组比较,差异有统计学意义(
P
<
0.05)。治疗6周,观察组CO低于对照组,差异有统计学意义(
P
<
0.05)。观察组总有效率高于对照组(
P
<
0.05)。治疗后半年随访,观察组2例(4.3%)患者再次住院,对照组8例(17.0%)患者再次住院,2组间差异有统计学意义(
P
<
0.05)。观察组和对照组发生室性心律失常分别为1、2例,发生低血压分别为4、6例,差异无统计学意义(
P
>
0.05)。2组均无药物性猝死、尿便常规异常、药物性肝肾损害、血糖异常发生。
结论
2
西医常规治疗联合泻肺利水合剂4号可降低气虚血瘀兼阳虚水泛型CHF患者的血清NT-proBNP,改善心功能,降低住院频次,效果优于单纯西医常规治疗,且未增加不良事件。
Objective
2
To evaluate the clinical effect of Xiefei Lishui Mixture in the treatment of chronic heart failure of qi and blood deficiency
blood stagnation and yang deficiency and water overflowing.
Methods
2
99 patients
who were admitted to the Cardiology Ward
Beijing Hospital of Traditional Chinese Medicine affiliated to the Capital Medical University and the Cardiology Ward of Shunyi Hospital of Beijing Hospital of Traditional Chinese Medicine from January 2020 to June 2022
were divided into control group(50) and observation group(49) by the random number method. The control group was routinely treated with western medicine according to the guidelines combined with oral Chinese medicine placebo
100 mL each time
twice a day after breakfast and dinner;and the observation group was routinely treated with western medicine according to the guidelines combined with hospital preparations of Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University number 4, 100 mL each time
twice a day with warm temperature.and the course of both groups was 6 weeks. Serum Serum n-terminal pro-brain natriuretic peptide (NT-proBNP) levels and cardiac function before and after treatment[Cardiac output (Cardiac output,CO),left ventricular ejection fraction (Left Ventricular Eject Fraction, LVEF), stroke output (Stroke volume, SV), left ventricular end-diastolic volume (Left ventricular end diastolic volume,LVEDV), Left ventricular end-systolic volume (left ventricular end-systolic volume,LVESV), Ratio of peak flow rate (E/A)], frequency of re-hospitalization, adverse events and efficacy were compared between the two groups before and after the treatment.
Results
2
After 2 and 6 weeks of treatment
the serum NT-proBNP levels in both groups were lower than before treatment (
P
<
0.05)
and the observation group was lower than the control group (
P
<
0.05). After 2 and 6 weeks of treatment
there were significant differences in LVEDV
LVEV
LVEF
E/A and SV between the observation group and the control group (
P
<
0.05). After 6 weeks of treatment
the CO in the observation group was lower than that in the control group
and the difference was statistically significant (
P
<
0.05). The total effective rate of the observation group was higher than that of the control group (
P
<
0.05).Six months after treatment through follow-up
two patients (4.3%) in the observation group were hospitalized again
which was less than that in the control group (8 cases (17.0%))
and the difference was statistically significant (
P
<
0.05). There were 1 and 2 cases of ventricular arrhythmia and 4 and 6 cases of hypotensi
on in the observation group and the control group
respectively
with no statistical significance (
P
>
0.05). There were no drug-induced sudden death
abnormal urine and stool routine
drug-induced liver and kidney damage and abnormal glucose in both groups.
Conclusion
2
Conventional treatment of western medicine combined with Xiefei Lishui Mixture no. 4 could reduce the serum NT-proBNP in patients with qi deficiency,blood stasis with Yang deficiency and water overflowing in chronic heart failure, improve cardiac function
reduce the frequency of hospitalization with better effect than the simple routine treatment of western medicine
and there is no increase in adverse events.
慢性心力衰竭气虚血瘀阳虚水泛泻肺利水合剂心功能
Chronic heart failureQi deficiency and blood stasisYang deficiency and water overflowingXiefei Lishui Mixturecardiac function
陈可冀,吴宗贵,朱明军,等.慢性心力衰竭中西医结合诊疗专家共识[J].心脑血管病防治,2016,16(5):340-347.
来晓磊, 尚菊菊, 刘红旭,等. 泻肺利水合剂联合西医常规方法治疗慢性缺血性心力衰竭气虚血瘀证疗效的真实世界、多中心、队列研究[J]. 中医杂志,2022,63(6):544-550.
陈嘉兴, 滕菲, 刘红旭. 温阳益气泻肺利水法治疗慢性心力衰竭阳虚水泛证的临床疗效评价[J]. 北京中医药,2017,36(12):1102-1105.
庄园, 刘红旭, 佟彤,等. 泻肺利水合剂干预慢性缺血性心力衰竭气虚水停证的随机、单盲、安慰剂对照研究[J]. 中西医结合心脑血管病杂志,2020,18(11):1671-1676.
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志, 2018, 46(10):30.
郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:77-85.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构